We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Collection of documents relating to COVID-19 treatments.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
DHSC publications relating to COVID-19 treatments and clinical trials.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Service personnel treated at the Royal Centre for Defence Medicine or the Defence Medical Rehabilitation Centre Headley Court.
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Visit the UK for medical treatment - check if you’re eligible and if you need a visa, what visa to apply for, what to do when you travel to the UK.
Information on cleaning an oil spill including your options, how to get a product approved and how long it will take.
The independent advisory group identified which patient groups are at highest risk of serious illness from COVID-19 and would benefit from new COVID-19 treatments.
Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Department of Health response to Raj Long’s independent report on the challenges faced when developing treatments for dementia.
Update to the independent advisory group report that identifies which patient groups are at highest risk of serious illness from COVID-19 and would benefit from new COVID-19 treatments.
Statistics to support improvements in decision making when planning alcohol and drug misuse treatment services.
Read about talking therapies and counselling for mental health problems.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.